ROCKWELL MEDICAL, INC. Increase (Decrease) in Insurance Settlements Receivable
ROCKWELL MEDICAL, INC. (RMTI) reported Increase (Decrease) in Insurance Settlements Receivable of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInsuranceSettlementsReceivable · last filed 2021-03-31
- ROCKWELL MEDICAL, INC. increase (decrease) in insurance settlements receivable for the quarter ending 2020-12-31 was $0.00.
- ROCKWELL MEDICAL, INC. increase (decrease) in insurance settlements receivable for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. increase (decrease) in insurance settlements receivable for the quarter ending 2020-06-30 was $0.00.
- ROCKWELL MEDICAL, INC. increase (decrease) in insurance settlements receivable for the quarter ending 2020-03-31 was $0.00.
- ROCKWELL MEDICAL, INC. increase (decrease) in insurance settlements receivable for fiscal 2020 was $0.00.
- ROCKWELL MEDICAL, INC. increase (decrease) in insurance settlements receivable for fiscal 2019 was -$371.00K, a 199.94% decline from fiscal 2018.
- ROCKWELL MEDICAL, INC. increase (decrease) in insurance settlements receivable for fiscal 2018 was $371.22K.
| Period end | Increase (Decrease) in Insurance Settlements Receivable 3 month | Increase (Decrease) in Insurance Settlements Receivable 6 month | Increase (Decrease) in Insurance Settlements Receivable 9 month | Increase (Decrease) in Insurance Settlements Receivable 9 month as first filed | Increase (Decrease) in Insurance Settlements Receivable 12 month | Increase (Decrease) in Insurance Settlements Receivable 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 derived: sum of 3 quarters · filed 2021-03-31 | $0.00 10-K · filed 2021-03-31 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 4 quarters · filed 2021-03-31 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2021-03-31 | $217.00 derived: sum of 4 quarters · filed 2021-03-31 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $217.00 derived: sum of 3 quarters · filed 2021-03-31 | $217.00 derived: sum of 4 quarters · filed 2021-03-31 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $217.00 derived: sum of 2 quarters · filed 2021-03-31 | $217.00 derived: sum of 3 quarters · filed 2021-03-31 | -$371.00K 10-K · filed 2021-03-31 | -$371.22K 10-K · filed 2020-03-17 | |
| 2019-09-30 | $217.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $217.00 derived: sum of 2 quarters · filed 2020-11-09 | -$371.00K 10-Q · filed 2020-11-09 | -$371.22K 10-Q · filed 2019-11-12 | -$499.78K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$371.22K 10-Q · filed 2020-08-10 | -$500.00K derived: sum of 3 quarters · filed 2020-08-10 | -$500.00K derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2019-03-31 | -$371.22K 10-Q · filed 2020-05-11 | -$500.00K derived: sum of 2 quarters · filed 2020-05-11 | -$500.00K derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | -$128.78K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$128.78K derived: sum of 2 quarters · filed 2020-03-17 | $371.22K 10-K · filed 2020-03-17 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $500.00K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $500.00K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |